Jeffrey D. Bray

机构：GlaxoSmithKline (United States)

发表论文 26 篇 · 总被引 1112 次 · h-index 14

代表论文

• U.S. Food and Drug Administration Approval: Carfilzomib for the Treatment of Multiple Myeloma (2013 · Clinical Cancer Research · 被引 244)
• Development of a Small-Molecule Serum- and Glucocorticoid-Regulated Kinase-1 Antagonist and Its Evaluation as a Prostate Cancer Therapeutic (2008 · Cancer Research · 被引 216)
• A Structural and in Vitro Characterization of Asoprisnil: A Selective Progesterone Receptor Modulator (2007 · Molecular Endocrinology · 被引 152)
• EADB: An Estrogenic Activity Database for Assessing Potential Endocrine Activity (2013 · Toxicological Sciences · 被引 77)
• Quantitative analysis of gene regulation by seven clinically relevant progestins suggests a highly similar mechanism of action through progesterone receptors in T47D breast cancer cells (2005 · The Journal of Steroid Biochemistry and Molecular Biology · 被引 61)
• Severe systemic sclerosis with anti-topoisomerase I Antibodies is associated with an HLA-DRw11 allele (1994 · Human Immunology · 被引 58)